These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 19117052)
1. Altered gene expression in breast cancer liver metastases. Erin N; Wang N; Xin P; Bui V; Weisz J; Barkan GA; Zhao W; Shearer D; Clawson GA Int J Cancer; 2009 Apr; 124(7):1503-16. PubMed ID: 19117052 [TBL] [Abstract][Full Text] [Related]
2. Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma. Erin N; Kale S; Tanrıöver G; Köksoy S; Duymuş O; Korcum AF Breast Cancer Res Treat; 2013 Jun; 139(3):677-89. PubMed ID: 23760857 [TBL] [Abstract][Full Text] [Related]
3. Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy. Gorczynski RM; Chen Z; Erin N; Khatri I; Podnos A PLoS One; 2014; 9(11):e113597. PubMed ID: 25409195 [TBL] [Abstract][Full Text] [Related]
4. Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists. Erin N; Nizam E; Tanrıöver G; Köksoy S Breast Cancer Res Treat; 2015 Feb; 150(1):57-69. PubMed ID: 25682075 [TBL] [Abstract][Full Text] [Related]
5. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Tabariès S; Dong Z; Annis MG; Omeroglu A; Pepin F; Ouellet V; Russo C; Hassanain M; Metrakos P; Diaz Z; Basik M; Bertos N; Park M; Guettier C; Adam R; Hallett M; Siegel PM Oncogene; 2011 Mar; 30(11):1318-28. PubMed ID: 21076473 [TBL] [Abstract][Full Text] [Related]
6. Nephronectin is Decreased in Metastatic Breast Carcinoma and Related to Metastatic Organs. Dilmac S; Erin N; Demir N; Tanriover G Pathol Oncol Res; 2018 Jul; 24(3):679-688. PubMed ID: 28842827 [TBL] [Abstract][Full Text] [Related]
7. A comparison of serum miRNAs influencing metastatic growth of EMT6 vs 4THM tumor cells in wild-type and CD200R1KO mice. Gorczynski RM; Zhu F; Chen Z; Kos O; Khatri I Breast Cancer Res Treat; 2017 Apr; 162(2):255-266. PubMed ID: 28160157 [TBL] [Abstract][Full Text] [Related]
8. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs. Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395 [TBL] [Abstract][Full Text] [Related]
10. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis. Dutertre M; Lacroix-Triki M; Driouch K; de la Grange P; Gratadou L; Beck S; Millevoi S; Tazi J; Lidereau R; Vagner S; Auboeuf D Cancer Res; 2010 Feb; 70(3):896-905. PubMed ID: 20103641 [TBL] [Abstract][Full Text] [Related]
11. Presence of S100A8/Gr1-Positive Myeloid-Derived Suppressor Cells in Primary Tumors and Visceral Organs Invaded by Breast Carcinoma Cells. Tanriover G; Eyinc MB; Aliyev E; Dilmac S; Erin N Clin Breast Cancer; 2018 Oct; 18(5):e1067-e1076. PubMed ID: 29804651 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Liu S; Goldstein RH; Scepansky EM; Rosenblatt M Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617 [TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618 [TBL] [Abstract][Full Text] [Related]
14. Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease. Kluger HM; Chelouche Lev D; Kluger Y; McCarthy MM; Kiriakova G; Camp RL; Rimm DL; Price JE Cancer Res; 2005 Jul; 65(13):5578-87. PubMed ID: 15994930 [TBL] [Abstract][Full Text] [Related]
15. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218 [TBL] [Abstract][Full Text] [Related]
16. JAM-A expression positively correlates with poor prognosis in breast cancer patients. McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747 [TBL] [Abstract][Full Text] [Related]
17. Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung. Al-Sahaf O; Wang JH; Browne TJ; Cotter TG; Redmond HP Ann Surg; 2010 Dec; 252(6):1037-43. PubMed ID: 21107114 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneous expression of tumor-associated genes in disseminated breast cancer cells. Zieglschmid V; Hollmann C; Gutierrez B; Krehan A; Kaul S; Böcher O Anticancer Res; 2007; 27(4A):1769-76. PubMed ID: 17649771 [TBL] [Abstract][Full Text] [Related]
19. Claudin-16 reduces the aggressive behavior of human breast cancer cells. Martin TA; Harrison GM; Watkins G; Jiang WG J Cell Biochem; 2008 Sep; 105(1):41-52. PubMed ID: 18442037 [TBL] [Abstract][Full Text] [Related]
20. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Eckhardt BL; Parker BS; van Laar RK; Restall CM; Natoli AL; Tavaria MD; Stanley KL; Sloan EK; Moseley JM; Anderson RL Mol Cancer Res; 2005 Jan; 3(1):1-13. PubMed ID: 15671244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]